Fill in the form below and our experts will get back to you within 1 business day.
Rapid, high-yield in vitro protein expression without the constraints of living cells. Synthesize functional proteins in hours instead of days using our optimized S30 extract platform.
Trusted by leading research and pharmaceutical institutions
1-3 business days from gene to protein
Express proteins lethal to living cells
Non-canonical amino acids and modifications
Advanced cell-free protein synthesis platform delivering rapid, high-quality protein expression
Go from gene to purified protein in 1-3 business days. No cell culture, no colony screening, no waiting weeks for expression.
Express proteins that would kill or cripple living cells. Bypass metabolic constraints entirely with our open reaction system.
Easy incorporation of non-canonical amino acids, labels, and modifications. Direct access to reaction components for experimental control.
From 50 uL screening reactions to multi-milligram production. Scale up without redesigning your workflow.
Every batch validated against control standards. Consistent yields and purity across multiple preparations with comprehensive QC.
Eliminate expensive fermentation runs and downstream processing. Get more data from smaller budgets.
Submit your gene sequence today and receive synthesized protein within days
Optimized platform technology for robust and reproducible protein expression
Our service utilizes optimized E. coli cell-free extract derived from engineered strains lacking RNase I. The extract contains all necessary transcription and translation machinery.
The reaction buffer contains precisely balanced components for maximum protein synthesis including amino acids, NTPs, and molecular crowding agents.
We accept various DNA template formats including plasmid DNA, linear DNA (PCR products), and mRNA for maximum experimental flexibility.
Comprehensive specifications for our E. coli CFPS platform
| Parameter | Specification |
|---|---|
| Expression System | E. coli Cell-Free (S30 Extract) |
| Transcription | T7 RNA Polymerase (phage-derived) |
| Protein Size Range | 10 - 230 kDa |
| Typical Yield | 0.5 - 1.0 mg/mL |
| Reaction Volume | 50 uL - 10 mL (customizable) |
| Template Format | Plasmid DNA, Linear DNA, mRNA |
| Incubation Temperature | 16C - 37C (adjustable) |
| Incubation Time | 4 - 24 hours |
| Quality Control | SDS-PAGE, Western Blot, Activity Assay |
| Delivery Format | Reaction mix, Purified protein, or Lyophilized |
Streamlined five-step process from template submission to protein delivery
Submit your gene sequence in plasmid or digital format
Prepare cell-free reaction mix with optimized components
Incubation at optimal temperature for protein synthesis
SDS-PAGE, concentration measurement, and validation
Shipped on dry ice with complete documentation
Our CFPS platform supports research and development in multiple fields
Our E. coli CFPS platform accelerates research workflows by eliminating the time-consuming steps of traditional expression systems. Get functional protein without cell transformation, colony screening, or fermentation optimization.
Parallel screening of hundreds of variants in microscale reactions dramatically accelerates protein engineering workflows. The cell-free format enables direct manipulation of reaction conditions without cell viability constraints.
The open nature of the cell-free system provides unprecedented access to the synthesis machinery. Incorporate non-canonical amino acids, fluorescent labels, and other modifications directly into your protein of interest.
Trusted by researchers worldwide for quality and reliability
"The cell-free system let us express a cytotoxic kinase domain that simply would not work in E. coli. We got functional protein in under a week."
"We screened 200+ variants in parallel using microscale reactions. The speed difference compared to traditional expression is remarkable."
"Incorporating unnatural amino acids for labeling was straightforward. The open nature of the system is a major advantage."
Our platform is backed by peer-reviewed research
Cui Y, Chen X, Wang Z, Lu Y, et al. BioDesign Research. 2022.
Comprehensive review of PURE system elements, design, and applications in prototyping, non-natural protein synthesis, and biosensors.
Deuker D, Asilonu E, Bracewell DG, Frank S, et al. ACS Synthetic Biology. 2024.
Exploration of CFPS for producing AAV5-like virus-like particles, demonstrating successful expression and particle assembly.
Piorino F, Styczynski MP, et al. ACS Synthetic Biology. 2023.
Investigation of sonication energy effects on cell-free protein synthesis productivity and optimization strategies.
Levine MZ, So B, Mullin AC, et al. ACS Synthetic Biology. 2021.
Development of cell-free auto-induction medium enabling 24-hour workflow with sfGFP yields exceeding 1 mg/mL.
Batista AC, Levrier A, Soudier P, et al. ACS Synthetic Biology. 2022.
Development of recBCD-deficient E. coli strains and optimized buffer enabling linear DNA expression without protection strategies.
Find answers to common questions about our service
Get a customized quote for your High-Yield E. coli Cell-Free Protein Synthesis (CFPS) System Service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.